AITRICS develops clinical decision-support software including AITRICS-VC (VitalCare), which analyzes real-time EMR data to predict patient deterioration, and is developing an LLM-based clinician copilot called V.Doc Pro. The company has obtained medical device approvals in Malaysia, Indonesia, Vietnam and Hong Kong and opened a Tokyo office in November 2025. AITRICS is based in Seoul's Gangnam district and was founded in 2016.
Builder’s Brief
AITRICS is a healthcare tool on Falcoscan. AI software that predicts patient deterioration from real-time hospital data. Falcoscan rates AITRICS with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. AITRICS is founded in 2016, currently at Series_c stage. Pricing: Paid.
Market position · Healthcare
How AITRICS compares in Healthcare
AITRICS's opportunity score of 84 ranks #51 of 192 live Healthcare tools on Falcoscan, 1.4 points above the category average of 82.6. Its saturation score is 11/100, against a category average of 11. 86 of the 192 live Healthcare tools carry a hot signal, and Falcoscan has recorded 8 shutdowns in the category.
The top-rated live Healthcare tools on Falcoscan, other than AITRICS, are DeepMind AlphaFold, Nuance DAX Copilot, Viz.ai AI Stroke Response, Tempus AI Diagnostics, and Viz.ai Stroke AI.
Is AITRICS still operating?
Yes. Falcoscan's operating checks list AITRICS as active.
Where is AITRICS based?
AITRICS is headquartered in Seoul, South Korea.
Does AITRICS have an API?
Falcoscan's records show no public API for AITRICS.